McGuire, J. J., Frieling, J. S., Lo, C. H., Li, T., Muhammad, A., Lawrence, H. R., . . . Lynch, C. C. (2021). Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)McGuire, Jeremy J., Jeremy S. Frieling, Chen Hao Lo, Tao Li, Ayaz Muhammad, Harshani R. Lawrence, Nicholas J. Lawrence, Leah M. Cook, et Conor C. Lynch. Mesenchymal Stem Cell-derived Interleukin-28 Drives the Selection of Apoptosis Resistant Bone Metastatic Prostate Cancer. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)McGuire, Jeremy J., et al. Mesenchymal Stem Cell-derived Interleukin-28 Drives the Selection of Apoptosis Resistant Bone Metastatic Prostate Cancer. Nature Portfolio, 2021.